Delivery Order SPE2DB25D3017-SPE2DB25FVHQQ

Award Date 4/8/25
Potential Completion Date 4/9/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BELBUCA 750 MCG FILM 60S. The contract has a ceiling value of $1,442.82 and is a firm fixed-price delivery order with a completion date of June 25, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This federal contract award, valued at $1,049.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BELBUCA 450 MCG FILM 60S, a pharmaceutical product. The contract is a firm fixed-price Delivery Order (DO) with an ultimate completion date of January 31, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of BELBUCA 750 MCG FILM 60S, a pharmaceutical product, and has a ceiling value of $1,460.16. The contract is a firm fixed-price, delivery order contract with a period of performance that runs through January 8, 2025. The contract does not have a set-aside designation, indicating it was competitively awarded....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,961.75 firm fixed-price delivery order is for the supply of BELBUCA 450 MCG FILM 60S, a medication used for pain management. The contract has an ultimate completion date of June 18, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BELBUCA 450 MCG FILM 60S, a prescription medication. The contract has a firm fixed price and a ceiling value of $1,646.20. It is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,945.04, is for the delivery of BELBUCA 900 MCG FILM 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 14, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,453.96 firm fixed-price delivery order is for the supply of BELBUCA 300 MCG FILM 60S, a prescription medication. The award has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,532.70 firm fixed-price delivery order is for the supply of BELBUCA 600 MCG Film 60S, a pharmaceutical product. The contract has an ultimate completion date of December 29, 2022 and was awarded on December 28, 2022. This award is associated with AmerisourceBergen's $999,999,999 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract, valued at $1,133.26, is for the delivery of the pharmaceutical product "BELBUCA 900 MCG FILM 60S" with a completion date of May 15, 2024. Amerisourcebergen, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,148.61 delivery order is for the supply of BELBUCA 450 MCG FILM 60S, a pharmaceutical product. The contract has a firm fixed price and is set to expire on September 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to...
  • SPE2DB25D3017
    Indefinite Delivery Contract
  • SPE2DB25D3017-SPE2DB25FVHQQ
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BELBUCA 600 MCG FILM 60S medical products. The contract has a ceiling value of $1,453.06 and runs through April 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 7/8/25, 2:22 PM